169 related articles for article (PubMed ID: 15035421)
21. [The CLASS study and its scientific statement. Ethical publishing rules neglected].
Wollheim FA
Lakartidningen; 2002 Oct; 99(40):3934-5. PubMed ID: 12422748
[No Abstract] [Full Text] [Related]
22. Phenidone, a dual inhibitor of cyclooxygenases and lipoxygenases, ameliorates rat paralysis in experimental autoimmune encephalomyelitis by suppressing its target enzymes.
Moon C; Ahn M; Wie MB; Kim HM; Koh CS; Hong SC; Kim MD; Tanuma N; Matsumoto Y; Shin T
Brain Res; 2005 Feb; 1035(2):206-10. PubMed ID: 15722060
[TBL] [Abstract][Full Text] [Related]
23. The COX-2 inhibitors--an update.
Furberg CD
Am Heart J; 2006 Aug; 152(2):197-9. PubMed ID: 16875896
[No Abstract] [Full Text] [Related]
24. Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies.
Birbara C; Ruoff G; Sheldon E; Valenzuela C; Rodgers A; Petruschke RA; Chang DJ; Tershakovec AM
Curr Med Res Opin; 2006 Jan; 22(1):199-210. PubMed ID: 16393445
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
[TBL] [Abstract][Full Text] [Related]
26. Celecoxib shown effective in preventing colon polyps.
Nelson NJ
J Natl Cancer Inst; 2006 May; 98(10):665-7. PubMed ID: 16705118
[No Abstract] [Full Text] [Related]
27. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
Patrignani P
Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
[No Abstract] [Full Text] [Related]
28. Comment on efficacy of rofecoxib and nimesulide in controlling post-extraction pain in oral surgery: a randomised comparative study.
Villa G
Curr Med Res Opin; 2004 Apr; 20(4):573-4; author reply 574. PubMed ID: 15119995
[No Abstract] [Full Text] [Related]
29. Does MOVES move the needle?
Meyer R
Ann Rheum Dis; 2015 May; 74(5):e35. PubMed ID: 25714932
[No Abstract] [Full Text] [Related]
30. A trial of adjuvant therapy in colorectal cancer: the VICTOR trial.
Pendlebury S; Duchesne F; Reed KA; Smith JL; Kerr DJ
Clin Colorectal Cancer; 2003 May; 3(1):58-60. PubMed ID: 12777194
[No Abstract] [Full Text] [Related]
31. The safety of the perioperative administration of cyclooxygenase-2 inhibitors for post-surgical pain.
Reuben SS
Acta Anaesthesiol Scand; 2005 Mar; 49(3):424; author reply 425. PubMed ID: 15752415
[No Abstract] [Full Text] [Related]
32. COX-2 inhibitors and pain after oral surgery - pertinent papers 2002-2003.
Meechan J
Br J Oral Maxillofac Surg; 2006 Apr; 44(2):163-5. PubMed ID: 16191457
[No Abstract] [Full Text] [Related]
33. The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats.
El-Medany A; Mahgoub A; Mustafa A; Arafa M; Morsi M
Eur J Pharmacol; 2005 Jan; 507(1-3):291-9. PubMed ID: 15659320
[TBL] [Abstract][Full Text] [Related]
34. [Rofecoxib-induced psychosis].
Sabolek M; Unrath A; Sperfeld AD; Connemann BJ; Kassubek J
Psychiatr Prax; 2007 May; 34(4):200-2. PubMed ID: 17160756
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
[TBL] [Abstract][Full Text] [Related]
36. Seminal pharmaceutical trials: maintaining masking in analysis.
Boers M
Lancet; 2002 Jul; 360(9327):100-1. PubMed ID: 12126815
[No Abstract] [Full Text] [Related]
37. Regulatory paternalism in the market for drugs: lessons from Vioxx and Celebrex.
Epstein RA
Yale J Health Policy Law Ethics; 2005; 5(2):741-70. PubMed ID: 16052898
[No Abstract] [Full Text] [Related]
38. Blood pressure in Native Americans switched from celecoxib to rofecoxib.
Fredy J; Diggins DA; Morrill GB
Ann Pharmacother; 2005 May; 39(5):797-802. PubMed ID: 15797981
[TBL] [Abstract][Full Text] [Related]
39. Drug safety. FDA panel urges caution on many anti-inflammatory drugs.
Couzin J
Science; 2005 Feb; 307(5713):1183-5. PubMed ID: 15731414
[No Abstract] [Full Text] [Related]
40. COX-2 selective drugs and cardiovascular risks: same data but discrepant conclusions?
Bannwarth B
Expert Opin Drug Saf; 2006 Jan; 5(1):1-2; author reply 1-2. PubMed ID: 16370948
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
